(EMAILWIRE.COM, November 12, 2019 ) Factors such as the growth in target patient population, technological advancements, favorable reimbursement scenario for minimally invasive surgeries, and the availability of clinical evidence for the safety and efficacy of occlusion procedures are driving the growth of the occlusion devices market.

Market Size
The global Occlusion Devices Market is projected to reach USD 3.55 Billion by 2023 from USD 2.74 Billion in 2018, at a CAGR of 5.3%

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249840809

“Based on product, the occlusion removal devices segment is estimated to have the largest share of the market in 2018.”
On the basis of product, the occlusion devices market is segmented into occlusion removal devices (balloon occlusion devices, stent retrievers, coil retrievers, and suction and aspiration devices), embolization devices (embolic coils and liquid embolic agents), tubal occlusion devices, and support catheters (microcatheters and guidewires). The occlusion removal devices segment is expected to account for the largest share of the global occlusion devices market in 2018.

“Based on application, the neurology segment is expected to account for the largest share of this market in 2018.”
On the basis of application, the occlusion devices market is categorized into neurology, cardiology, peripheral vascular diseases, urology, oncology, and gynecology. Neurology applications are expected to account for the largest share of the occlusion devices market in 2018.

Recent Developments
• In November 2015, the company commercialized its Angiojet Zelante DVT thrombectomy catheter.
• In March 2016, Boston Scientific collaborated with Mayo Clinic (US) to develop interventional medical devices including occlusion devices.

For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=249840809